(Reuters) -World’s largest dialysis specialist Fresenius Medical Care reported first-quarter results above market expectations on Tuesday, as revenue grew organically in all its segments.
The German company’s revenue was 4.88 billion euros ($5.53 billion) in the quarter, slightly above analysts’ average estimate of 4.85 billion in a poll compiled by Vara Research. That was up from 4.73 billion euros in the same period in 2024.
Operating income adjusted for special items grew to 457 million euros from 403 million last year, beating analysts’ expectations of 446 million euros.
FMC, which makes most of its revenue in the United States, also confirmed its financial guidance for 2025.
($1 = 0.8831 euros)
(Reporting by Isabel Demetz in Gdansk, editing by Milla Nissi-Prussak)
Comments